SERA Sera Prognostics, Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.

$10.22  -0.20 (-1.92%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  07/15/2021
Outstanding shares:  29,293,831
Average volume:  23,129
Market cap:   $305,241,719
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    81749D107
ISIN:        US81749D1072
Sedol:      BN2T5R7
Valuation   (See tab for details)
PE ratio:   -13.29
PB ratio:   2.09
PS ratio:   0.00
Return on equity:   -18.60%
Net income %:   -45,000.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy